GLOBAL CLINICAL SCHOLARS RESEARCH TRAINING PROGRAM
HMS.HARVARD.EDU/GCSRT
B101 - Survey Design
!,-7'3967)'3:)678,)'6%*8-2+3*796:)=
59)78-3278,)()7-+23*796:)=7%2((-**)6)28
7%140-2+463')(96)78,%8%6)97)(-246%'8-')
32+78%2(-2+&%7-'46-2'-40)73*796:)=()7-+2
%6)'3:)6)( 8%8-78-'%0%74)'873*%2%0=>-2+
'3140)<796:)=(%8%;-00&)*)%896)( -2'09(-2+
8,))**)'873*(-**)6)28()7-+2*)%896)732&-%7
%2(:%6-%2')-**)6)281)8,3(73*:%6-%2')
)78-1%8-32*36786%8-*-)(%2('0978)6)(7%140)7
;-00&)'314%6)(!,),%2(0-2+3*796:)=
;)-+,87;-00&)(-7'977)(!,)'%4%&-0-8-)73*
8%8%*3679',%2%0=7)7;-00&))14,%7->)(
B102 - Drug Development, Drug Regulation,
and Drug Safety
69+():)0341)28(69+6)+90%8-32%2((69+
7%*)8=%6)'3140)<%2(,-+,0=-28)66)0%8)(
%'8-:-8-)78,%8-2:30:)&6-2+-2+%4,%61%')98-'%0
(-%+2378-'36():-')(-7'3:)6=83%4463:%0
%2(1%6/)8 )1-2%6834-'7-2'09()How are
Drugs Discovered and DevelopedCase
Study of the Pre-clinical Stages of Drug
DevelopmentMoving a Compound Through
the Drug Development ProcessGood
Manufacturing Practices---a Global Perspective
%2(Overview of Diagnostic Device Develop-
ment:)6:-);73*(69+6)+90%8-32*3'97-2+
328,)%'8-:-8-)73*8,)" 33(%2(69+
(1-2-786%8-32%2(9634)%2)(-'-2)7
+)2'=%6)%073'3:)6)(%780=0)'896)732
(69+7%*)8=-2'09()8,)*3003;-2+834-'7
Methods in Drug Safety Monitoring %2(
Drug Safety in the Pre- and Post-approval
Phases!,)'3967)-70%6+)0=;)&-2%6&%7)(
%2('327-7873*(-7'977-327&=)<4)687*631
%'%()1-%-2(9786= %2(+3:)621)28;-8,
=)%673*,%2(732)<4)6-)2');-8,0%6+)%2(
71%004,%61%')98-'%0&-38)',2303+=%2(
6)0%8)(36+%2->%8-327
C101 - Principles and Practice of
Clinical Trials
!,-7'3967)*3'97)732,3;83'32(9'8
'0-2-'%086-%07)**)'8-:)0=!,)'3967)'328)28
-2'09()70)'896)732789(=()7-+2%2(
-140)1)28%8-32-2'09(-2+(-**)6)28()7-+27
)2(43-287789(=46383'30789(=43490%8-32
6)'69-81)28&%7)0-2)%77)771)286%2(31
->%8-32786%8-*-'%8-32%2(&0-2(-2+8,)6/)=
-779)78,%8%6)'3:)6)(-2'09()(%8%%2%0=7-7
%2(7%140)7->)%2(43;)686)%81)28
6)+-1)27%2(*3003;94463')(96)7%2(
132-836-2+%2(-28)6-1%2%0=7-740%27
%780=38,)6%6)%7'3:)6)(-2'09()(%8%
1%2%+)1)28%2()8,-'%0-779)7-2'09(-2+
4638)'8-323*,91%279&.)'87
C102 - Introduction to Advanced
Quantitative Methods
!,-7'3967);-00463:-()789()287;-8,8,)
%440-'%8-323*%(:%2')(59%28-8%8-:)1)8,3(7
%78,)=4)68%-283!86%270%8-32%06)7)%6',
!34-'7-2'09()%23:)6:-);3*'314%6%8-:)
%2('378)**)'8-:)2)776)7)%6',1)8%
%2%0=7-759%7-)<4)6-1)28%0()7-+27
-2'09(-2+-278691)28%0:%6-%&0)7%2(1%6+-2%0
7869'896%013()0-2+4634)27-8=7'36)7%2(
8-1)7)6-)7%2%0=7-7
!#" 
!#" 
?&=8,)6)7-()28%2()003;73*%6:%6(300)+)
GLOBAL CLINICAL SCHOLARS RESEARCH TRAINING PROGRAM
PROGRAM CURRICULUM
JUNE 21, 2014 TO JUNE 6, 2015
!,)%6:%6()(-'%0 ',33003&%00-2-'%0 ',30%67)7)%6',!6%-2-2+
 !63+6%1'966-'9091-7()7-+2)(83)2%&0)7',30%6783():)034
/23;0)(+)%2(7,%64)27/-007-2'0-2-'%06)7)%6',
"!!#" 
!,)'966-'9091B7*392(%8-32%2()0)'8-:)'3967)7%003;7',30%67833&8%-2
%&63%(*92(3*/23;0)(+)-2'0-2-'%06)7)%6',%2(8,)23:)60%=74)'-%0->)(
-2*361%8-32-28,)-6'32')286%8-323*)-8,)6%(:%2')()4-()1-303+=
4- !36'0-2-'%086-%07!6-%07 !
38,'32')286%8-3276)59-6)7',30%67838%/)8,))0)'8-:)'3967)7%2(
8,)-6',3-')3*)0)'8-:)'3967)7)4)2(-2+328,)'32')286%8-327',30%67
;-008%/))-8,)6Principles and Practice of Clinical Trials 36Introduction to
Advanced Quantitative Methods -28,))0)'8-:)'3967)7
 !!
!6%-2-2+-240%22-2+%2(;6-8-2+%'0-2-'%06)7)%6',463437%0;-00&)%''31
40-7,)(8,639+,8,)%47832)63.)'8%92',)((96-2+$36/7,34
7',30%67;-00():)034%6)7)%6',59)78-32%2(&)+-2;6-8-2+8,)-6463437%07
))(&%'/328,)463437%0;-00&)463:-()(&=*%'908=
(6%*83*8,)463437%0-7(9)%6',8,)(%=%*8)6746-2+&6)%/
)2(7!,-7(6%*8;-00&)6):-);)(&=4))67%2(*%'908=&)*36)7',30%67
():)0348,)-6*-2%0:)67-327%2(79&1-88,)132%=!,)834
3*7',30%67;-00&)-2:-8)(8346)7)288,)-6789(-)7(96-2+$36/7,34
 !"""!
GLOBAL CLINICAL SCHOLARS RESEARCH TRAINING PROGRAM
HMS.HARVARD.EDU/GCSRT
GLOBAL CLINICAL SCHOLARS RESEARCH TRAINING PROGRAM
HMS.HARVARD.EDU/GCSRT
GLOBAL CLINICAL SCHOLARS RESEARCH TRAINING PROGRAM
HMS.HARVARD.EDU/GCSRT
F101 - Introduction to Biostatistics
!,-7'3967)463:-()7%8,3639+,-2863(9'8-32
838,)1378'311320=97)(&-378%8-78-'7
8)',2-59)7*36'0-2-'%06)7)%6', 4)'-*-'834-'7
-2'09()83307*36()7'6-&-2+')286%08)2()2'=
%2(:%6-%&-0-8=-2(%8%1)8,3(7*364)6*361-2+
-2*)6)2')3243490%8-321)%27%2(4634368-327
:-%7%140)(%8%78%8-78-'%0,=438,)7-78)78-2+
%2(-87%440-'%8-3283+6394'314%6-7327%2(
-779)73*43;)6%2(7%140)7->)-2789(=
()7-+27!,)6)-7%2-2863(9'8-32837-140)
0-2)%6 6)+6)77-32%2(796:-:%0%2%0=7-7$,-0)
8,)6)%6)731)*36190%)%2('31498%8-32%0
)0)1)287 97-2+ 8%8% 8,))14,%7-7-732
-28)646)8%8-32%2('32')487
F102 - Introduction to Epidemiology
!,-7-2863(9'836='3967)-2)4-()1-303+=
46)7)287%23:)6:-);&98238%()8%-0)((-7
'977-32 3*8,)&%7-'1)8,3(73*)4-()1-303+=
%2(8,)-6%440-'%8-32783'0-2-'%06)7)%6',
)'896)7)<4036)79',&%7-'46-2'-40)73*
)4-()1-303+=%78,)-14368%2')3*1)%796)
1)28 -2'09(-2+8=4)73*398'31)1)%796)7
%2(1)%796)73*%773'-%8-32(-:)67)%66%=
3*789(=()7-+27%:%-0%&0)-2'0-2-'%06)7)%6',
-2'09(-2+'63777)'8-32%0789(-)7'3,368
789(-)7'%7)'328630789(-)7%2()<4)6-1)28%0
()7-+278=4)73*438)28-%0&-%7)7-2'09(-2+
7)0)'8-32&-%7%2(1)%796)1)28&-%7
'32*392(-2+%2(1)8,3(7*36-87%:3-(%2')
%2('328630%2()**)'813(-*-'%8-32
F103 - Applied Regression
!,)'3967)-7()7-+2)(*36789()287;,3
,%:)'3140)8)(-)789()287;-8,%
+33(;36/-2+/23;0)(+)3*)0)1)28%6=
()7'6-48-:)78%8-78-'77%140-2+(-786-&98-327
32)%2(8;37%140)8)787*361)%27%2(
4634368-327'366)0%8-32%2(&%7-'0-2)%6%2(
1908-40)6)+6)77-3213()0&9-0(-2+2-8-%00=
0)'896)7;-00)<4036)+)2)6%0'32')487-20-2)%6
6)+6)77-32%2('327-()66)7-(9%0%2%0=7-7%2(
(%8%86%27*361%8-327)'896)7;-00%((6)77
1908-40)0-2)%66)+6)77-32-2'09(-2+'327-()6%
8-32 3*'32*392(-2+%2()**)'813(-*-'%8-32
3()0&9-0(-2+;-00&))14,%7->)(%780=
7):)6%00)'896)7;-00)<4036)834-'7-203+-78-'%0
6)+6)77-32-2'09(-2+<!%&0)7%2(786%8-*-'%
8-32 13()0&9-0(-2+%2(%77)771)283*
+33(2)773**-8%2(71338,-2+%2(
+)2)6%0->)(%((-8-:)13()07
F104 - Survival Analysis
!,-7'3967)-7()7-+2)(*36789()287;,3
,%:)'3140)8)(%2(8&9-0(732
8,)&%7-''32')4873*796:-:%0%2%0=7-7(-7
'977)(-2-2'09(-2+,%>%6(*92'8-327
796:-:%0*92'8-3278=4)73*')2736-2+%2(
8692'%8-32%40%2)-)6)78-1%8)703+6%2/
8)787%2(8,)-6+)2)6%0->%8-32!,)'3967)
-2863(9')778%8-78-'%013()07%2(1)8,3(7
97)*90*36%2%0=>-2+92-:%6-%8)%2(1908-:%6-%8)
*%-096)8-1)(%8%*8)6'3140)8-2+8,-7
'3967)789()287;-00&)%&0)83()7'6-&)
8-1)83):)28(%8%%2('314%6)+63947;-8,
%8-1)83):)28398'31)-28)646)88,)'3)**-
'-)287%2('328630*36'32*392(-2+97-2+%
3<4634368-32%0,%>%6(7 13()0-28)646)8
-28)6%'8-328)617%2(-2'36436%8)8-1):%6=-2+
'3:%6-%8)7-2%3<13()0%7;)00%7%77)77
8,)4634368-32%0,%>%6(7%779148-32%780=
789()287;-000)%62,3;83'3140)8)%7%140)
7->)'%0'90%8-32*36%796:-:%0789(=
F105 - Causal Design
%97%0-2*)6)2')-7%23:)6%6',-2+3&.)'8-:)
3*1378*36173*1)(-'%0%2()4-()1-303+-'%0
-2:)78-+%8-32)=59)78-327979%00='327-78
3*;,)8,)6%2-28)6:)28-32;36/7%2(8,))<
8)283*8,)&)2)*-8%2(;,)8,)6-8'%97)7
,%61$,-0)%6%2(31->)('3286300)(86-%0()
7-+2-7'327-()6)(8,)137843;)6*90;%=83
-2*)6'%97%0-8=79',789(-)71%=238&)4377-
&0)36*)%7-&0)%2(%23&7)6:%8-32%0%4463%',
1%=&)2)')77%6=83%88%-2'%97%0-2*)6)2')
!,-7'3967)&9-0(73288,))2(3*8,)
'3967)789()287;-00,%:)%())4)692()678%2(
-2+ 3*3&7)6:%8-32%0%4463%',)7)74)'-%00=
*6318,)4)674)'8-:)3*3:)6'31-2+8,)463&
0)13*'32*392(-2+ 89()287;-00&)%&0)83
()*-2)'32*392(-2+%2(():)034%4463%',)7
83;%6(-()28-*=-2+'32*392()677%7%
7869'896%0%4463%',83-()28-*=-2+'32*392()67
;-00&),-+,0-+,8)(8,)6834-'7;-00-2'09()
8,)690)73*7)4%6%8-32 %2('32(-8-32-2+32
'31132)**)'87634)27-8=7'36)7;-00&)
-2863(9')(!,)(-**)6)2')7&)8;))2
6%2(31->)(86-%07%2(3&7)6:%8-32%0789(-)7
%6)'327-()6)(%2(59%7-)<4)6-1)28%0
()7-+27-2863(9')(
F106 - Longitudinal and Correlated Data
032+-89(-2%0789(=6)*)6783%2-2:)78-+%8-32;,)6)
398'31)7%2(4377-&0=86)%81)28736)<43796)7
%6)'300)'8)(%81908-40)*3003;948-1)7032+-89(-
2%0789(=+)2)6%00==-)0(71908-40)36@6)4)%8)(A
1)%796)1)28732)%',79&.)'8;,-',1%='366)
0%8)3:)68-1)$-8,'366)0%8)(398'31)7-8-797)*90
8392()678%2(8,)786)2+8,%2(4%88)623*'366)0%
8-327,%6%'8)6->-2+'366)0%8-32'%2&)%4463%',)(
97-2+1-<)()**)'8713()0736+)2)6%0->)()78-1%8
-2+)59%8-327!,-7'3967)'3:)671)8,3(7
83%2%0=>)032+-89(-2%0(%8%-2'09(-2+8,)97)3*
0-2)%66)+6)77-3213()07!34-'7;-00-2'09()
430=231-%086)2(7*368-1))+0-2)%63659%(6%8-'
%2(0-2)%61-<)()**)'8713()0788,))2(3*8,)
'3967)789()287;-00&)%&0)83-28)646)88,)6)79087
*631%1908-0):)013()0%2(92()678%2(,3;83-2
'36436%8)1908-40)6%2(31)**)'87-2838,)13()0
89()287;-00&)%&0)8392()678%2(8,)8=4)73*
1-77-2+(%8%8,%83''96-2032+-89(-2%0%2('6377
7)'8-32%0%2%0=7-7%7;)00%792()678%2(8,)
%779148-327%773'-%8)(;-8,)%',%2%0=7-7%4
463%',!,-7'3967) 6)59-6)7'3140)8-323*
%2(
F107 - Special Topics in Biostatistics
!,-7'3967)7))/7837=28,)7->)8,)-14368%2')3*
/)=834-'78,%8,%:)%06)%(=&))2'3:)6)()+
43;)6%2%0=7-7%2(7%140)7->)%2((-7'977
38,)6-14368%2878%8-78-'%0834-'779',%7%+6))1)28
789(-)7%2(*%'836-%0()7-+2!,)0)'896)7;-0040%=
%2-28)+6%8-:)630);-8,0)'896)7-2%2(
36)<%140)8,)43;)6%2%0=7-70)'896)
-()28-*-)7%2((-78-2+9-7,)78,)()7-+2*%'8367
%**)'8-2+8,)46)'-7-32%2(43;)63*%40%22)(-2
:)78-+%8-32%2(%((6)77)78,)86%()3**7 %132+
()7-+24%6%1)8)67;-8,-2'32786%-2873*8-1)%2(
6)7396')788,))2(3*8,)'3967)789()287;-00&)
%&0)8346)4%6)%8,3639+,%2(4)68-2)2878%8-78-'%0
.978-*-'%8-32*367%140)7->)46)'-7-3243;)6%2(
()8)'8%&0))**)'87-2%40%22)(-2:)78-+%8-32%7;)00
%7-28)646)8%2():%09%8)8,)43;)6%2%0=7-7 %74)'87
3*%6)7)%6',463437%03649&0-7,)(6)4368
"!"  !
A101 - Career and Leadership Development
!,-7'3967))<%1-2)7(-**)6)28%74)'873*;36/
-2+%2(0)%(-2+%8)%1)'896)7;-00(-7'977
8,)2))(831%2%+)%8%0)28)(+63943*4)340)
)**)'8-:)0=4-03879'')77*90'300%&36%8-327;-8,-2
%2(3987-()%+63942%:-+%8)8,)'3140)<-8-)7
3*8,)-278-898-32%2(1%2%+)8,)-2):-8%&0)
'32*0-'878,%8%6-7)-2%,-+,78%/)7)2:-6321)28
A102 - Ethics and Regulation
!,-7'3967)6):-);7731)'31132',%00)2+)7
-28,)'32(9'8%2(6):-);3*&-31)(-'%0,91%2
79&.)'876)7)%6',)'896)7)<%1-2)8,),-7836=
%2():3098-323*)8,-'%0'3()7%2(6)+90%8-327
8,)630)%2(6)74327-&-0-8=3*4,=7-'-%27%7-2
:)78-+%83678,)46)4%6%8-323*6)7)%6',46383'30
%440-'%8-327%2(-2*361)('327)28(3'91)287
%2(8,)',%00)2+)73*'32(9'8-2+6)7)%6',
-2:30:-2+',-0(6)2%2(%(30)7')287
A103 - Biostatistical Computing
!,)%&-0-8=83-14368(%8%-283%78%8-78-'%0
4%'/%+)*631%(%8%&%7)36<')0746)%(7,))8
-7'327-()6)()77)28-%0-2'0-2-'%06)7)%6',
2863(9'836=0)'896)7;-00'327-783*8)%',-2+8,)
&%7-'*92'8-3273*8,) 8%8%463+6%1-2'09(-2+
0)%62-2+/)='311%2(7'6)%8-2+%(3*-0)
+)88-2+(%8%-2838,)7,%4)2))()(*36%2%0=7-7
%2(',)'/-2+*36)6636736)%(:%2')(0)'896)7
;-00*3'973297-2+ 8%8%*366)+6)77-32%2(
796:-:%0%2%0=7-7%780=8,)6);-00&)0)'896)7
32():)034-2+430-7,)(1%297'6-486)%(=8%&0)7
%2(*-+96)7
!#" 
2013-14 GCSRT Program Scholars
2
3
“GCSRT is a great opportunity for focusing
o
n the concepts of epidemiology, clinical
trials, and biostatistics.”
Santi Trimarchi, MD, PhD
U
niversity of Milan, San Donato Milanese, Italy
"!"  
“The online courses provide flexibility in my
schedule, and the workshops are a valuable tool
for networking and for team building.”
Krishna Soujanya Gunturu, MD
Tufts Medical Center, Boston, Mass., USA
GLOBAL CLINICAL SCHOLARS RESEARCH TRAINING PROGRAM
HMS.HARVARD.EDU/GCSRT
GLOBAL CLINICAL SCHOLARS RESEARCH TRAINING PROGRAM
HMS.HARVARD.EDU/GCSRT
F101 - Introduction to Biostatistics
!,-7'3967)463:-()7%8,3639+,-2863(9'8-32
838,)1378'311320=97)(&-378%8-78-'7
8)',2-59)7*36'0-2-'%06)7)%6', 4)'-*-'834-'7
-2'09()83307*36()7'6-&-2+')286%08)2()2'=
%2(:%6-%&-0-8=-2(%8%1)8,3(7*364)6*361-2+
-2*)6)2')3243490%8-321)%27%2(4634368-327
:-%7%140)(%8%78%8-78-'%0,=438,)7-78)78-2+
%2(-87%440-'%8-3283+6394'314%6-7327%2(
-779)73*43;)6%2(7%140)7->)-2789(=
()7-+27!,)6)-7%2-2863(9'8-32837-140)
0-2)%6 6)+6)77-32%2(796:-:%0%2%0=7-7$,-0)
8,)6)%6)731)*36190%)%2('31498%8-32%0
)0)1)287 97-2+ 8%8% 8,))14,%7-7-732
-28)646)8%8-32%2('32')487
F102 - Introduction to Epidemiology
!,-7-2863(9'836='3967)-2)4-()1-303+=
46)7)287%23:)6:-);&98238%()8%-0)((-7
'977-32 3*8,)&%7-'1)8,3(73*)4-()1-303+=
%2(8,)-6%440-'%8-32783'0-2-'%06)7)%6',
)'896)7)<4036)79',&%7-'46-2'-40)73*
)4-()1-303+=%78,)-14368%2')3*1)%796)
1)28 -2'09(-2+8=4)73*398'31)1)%796)7
%2(1)%796)73*%773'-%8-32(-:)67)%66%=
3*789(=()7-+27%:%-0%&0)-2'0-2-'%06)7)%6',
-2'09(-2+'63777)'8-32%0789(-)7'3,368
789(-)7'%7)'328630789(-)7%2()<4)6-1)28%0
()7-+278=4)73*438)28-%0&-%7)7-2'09(-2+
7)0)'8-32&-%7%2(1)%796)1)28&-%7
'32*392(-2+%2(1)8,3(7*36-87%:3-(%2')
%2('328630%2()**)'813(-*-'%8-32
F103 - Applied Regression
!,)'3967)-7()7-+2)(*36789()287;,3
,%:)'3140)8)(-)789()287;-8,%
+33(;36/-2+/23;0)(+)3*)0)1)28%6=
()7'6-48-:)78%8-78-'77%140-2+(-786-&98-327
32)%2(8;37%140)8)787*361)%27%2(
4634368-327'366)0%8-32%2(&%7-'0-2)%6%2(
1908-40)6)+6)77-3213()0&9-0(-2+2-8-%00=
0)'896)7;-00)<4036)+)2)6%0'32')487-20-2)%6
6)+6)77-32%2('327-()66)7-(9%0%2%0=7-7%2(
(%8%86%27*361%8-327)'896)7;-00%((6)77
1908-40)0-2)%66)+6)77-32-2'09(-2+'327-()6%
8-32 3*'32*392(-2+%2()**)'813(-*-'%8-32
3()0&9-0(-2+;-00&))14,%7->)(%780=
7):)6%00)'896)7;-00)<4036)834-'7-203+-78-'%0
6)+6)77-32-2'09(-2+<!%&0)7%2(786%8-*-'%
8-32 13()0&9-0(-2+%2(%77)771)283*
+33(2)773**-8%2(71338,-2+%2(
+)2)6%0->)(%((-8-:)13()07
F104 - Survival Analysis
!,-7'3967)-7()7-+2)(*36789()287;,3
,%:)'3140)8)(%2(8&9-0(732
8,)&%7-''32')4873*796:-:%0%2%0=7-7(-7
'977)(-2-2'09(-2+,%>%6(*92'8-327
796:-:%0*92'8-3278=4)73*')2736-2+%2(
8692'%8-32%40%2)-)6)78-1%8)703+6%2/
8)787%2(8,)-6+)2)6%0->%8-32!,)'3967)
-2863(9')778%8-78-'%013()07%2(1)8,3(7
97)*90*36%2%0=>-2+92-:%6-%8)%2(1908-:%6-%8)
*%-096)8-1)(%8%*8)6'3140)8-2+8,-7
'3967)789()287;-00&)%&0)83()7'6-&)
8-1)83):)28(%8%%2('314%6)+63947;-8,
%8-1)83):)28398'31)-28)646)88,)'3)**-
'-)287%2('328630*36'32*392(-2+97-2+%
3<4634368-32%0,%>%6(7 13()0-28)646)8
-28)6%'8-328)617%2(-2'36436%8)8-1):%6=-2+
'3:%6-%8)7-2%3<13()0%7;)00%7%77)77
8,)4634368-32%0,%>%6(7%779148-32%780=
789()287;-000)%62,3;83'3140)8)%7%140)
7->)'%0'90%8-32*36%796:-:%0789(=
F105 - Causal Design
%97%0-2*)6)2')-7%23:)6%6',-2+3&.)'8-:)
3*1378*36173*1)(-'%0%2()4-()1-303+-'%0
-2:)78-+%8-32)=59)78-327979%00='327-78
3*;,)8,)6%2-28)6:)28-32;36/7%2(8,))<
8)283*8,)&)2)*-8%2(;,)8,)6-8'%97)7
,%61$,-0)%6%2(31->)('3286300)(86-%0()
7-+2-7'327-()6)(8,)137843;)6*90;%=83
-2*)6'%97%0-8=79',789(-)71%=238&)4377-
&0)36*)%7-&0)%2(%23&7)6:%8-32%0%4463%',
1%=&)2)')77%6=83%88%-2'%97%0-2*)6)2')
!,-7'3967)&9-0(73288,))2(3*8,)
'3967)789()287;-00,%:)%())4)692()678%2(
-2+ 3*3&7)6:%8-32%0%4463%',)7)74)'-%00=
*6318,)4)674)'8-:)3*3:)6'31-2+8,)463&
0)13*'32*392(-2+ 89()287;-00&)%&0)83
()*-2)'32*392(-2+%2(():)034%4463%',)7
83;%6(-()28-*=-2+'32*392()677%7%
7869'896%0%4463%',83-()28-*=-2+'32*392()67
;-00&),-+,0-+,8)(8,)6834-'7;-00-2'09()
8,)690)73*7)4%6%8-32 %2('32(-8-32-2+32
'31132)**)'87634)27-8=7'36)7;-00&)
-2863(9')(!,)(-**)6)2')7&)8;))2
6%2(31->)(86-%07%2(3&7)6:%8-32%0789(-)7
%6)'327-()6)(%2(59%7-)<4)6-1)28%0
()7-+27-2863(9')(
F106 - Longitudinal and Correlated Data
032+-89(-2%0789(=6)*)6783%2-2:)78-+%8-32;,)6)
398'31)7%2(4377-&0=86)%81)28736)<43796)7
%6)'300)'8)(%81908-40)*3003;948-1)7032+-89(-
2%0789(=+)2)6%00==-)0(71908-40)36@6)4)%8)(A
1)%796)1)28732)%',79&.)'8;,-',1%='366)
0%8)3:)68-1)$-8,'366)0%8)(398'31)7-8-797)*90
8392()678%2(8,)786)2+8,%2(4%88)623*'366)0%
8-327,%6%'8)6->-2+'366)0%8-32'%2&)%4463%',)(
97-2+1-<)()**)'8713()0736+)2)6%0->)()78-1%8
-2+)59%8-327!,-7'3967)'3:)671)8,3(7
83%2%0=>)032+-89(-2%0(%8%-2'09(-2+8,)97)3*
0-2)%66)+6)77-3213()07!34-'7;-00-2'09()
430=231-%086)2(7*368-1))+0-2)%63659%(6%8-'
%2(0-2)%61-<)()**)'8713()0788,))2(3*8,)
'3967)789()287;-00&)%&0)83-28)646)88,)6)79087
*631%1908-0):)013()0%2(92()678%2(,3;83-2
'36436%8)1908-40)6%2(31)**)'87-2838,)13()0
89()287;-00&)%&0)8392()678%2(8,)8=4)73*
1-77-2+(%8%8,%83''96-2032+-89(-2%0%2('6377
7)'8-32%0%2%0=7-7%7;)00%792()678%2(8,)
%779148-327%773'-%8)(;-8,)%',%2%0=7-7%4
463%',!,-7'3967) 6)59-6)7'3140)8-323*
%2(
F107 - Special Topics in Biostatistics
!,-7'3967)7))/7837=28,)7->)8,)-14368%2')3*
/)=834-'78,%8,%:)%06)%(=&))2'3:)6)()+
43;)6%2%0=7-7%2(7%140)7->)%2((-7'977
38,)6-14368%2878%8-78-'%0834-'779',%7%+6))1)28
789(-)7%2(*%'836-%0()7-+2!,)0)'896)7;-0040%=
%2-28)+6%8-:)630);-8,0)'896)7-2%2(
36)<%140)8,)43;)6%2%0=7-70)'896)
-()28-*-)7%2((-78-2+9-7,)78,)()7-+2*%'8367
%**)'8-2+8,)46)'-7-32%2(43;)63*%40%22)(-2
:)78-+%8-32%2(%((6)77)78,)86%()3**7 %132+
()7-+24%6%1)8)67;-8,-2'32786%-2873*8-1)%2(
6)7396')788,))2(3*8,)'3967)789()287;-00&)
%&0)8346)4%6)%8,3639+,%2(4)68-2)2878%8-78-'%0
.978-*-'%8-32*367%140)7->)46)'-7-3243;)6%2(
()8)'8%&0))**)'87-2%40%22)(-2:)78-+%8-32%7;)00
%7-28)646)8%2():%09%8)8,)43;)6%2%0=7-7 %74)'87
3*%6)7)%6',463437%03649&0-7,)(6)4368
"!"  !
A101 - Career and Leadership Development
!,-7'3967))<%1-2)7(-**)6)28%74)'873*;36/
-2+%2(0)%(-2+%8)%1)'896)7;-00(-7'977
8,)2))(831%2%+)%8%0)28)(+63943*4)340)
)**)'8-:)0=4-03879'')77*90'300%&36%8-327;-8,-2
%2(3987-()%+63942%:-+%8)8,)'3140)<-8-)7
3*8,)-278-898-32%2(1%2%+)8,)-2):-8%&0)
'32*0-'878,%8%6-7)-2%,-+,78%/)7)2:-6321)28
A102 - Ethics and Regulation
!,-7'3967)6):-);7731)'31132',%00)2+)7
-28,)'32(9'8%2(6):-);3*&-31)(-'%0,91%2
79&.)'876)7)%6',)'896)7)<%1-2)8,),-7836=
%2():3098-323*)8,-'%0'3()7%2(6)+90%8-327
8,)630)%2(6)74327-&-0-8=3*4,=7-'-%27%7-2
:)78-+%83678,)46)4%6%8-323*6)7)%6',46383'30
%440-'%8-327%2(-2*361)('327)28(3'91)287
%2(8,)',%00)2+)73*'32(9'8-2+6)7)%6',
-2:30:-2+',-0(6)2%2(%(30)7')287
A103 - Biostatistical Computing
!,)%&-0-8=83-14368(%8%-283%78%8-78-'%0
4%'/%+)*631%(%8%&%7)36<')0746)%(7,))8
-7'327-()6)()77)28-%0-2'0-2-'%06)7)%6',
2863(9'836=0)'896)7;-00'327-783*8)%',-2+8,)
&%7-'*92'8-3273*8,) 8%8%463+6%1-2'09(-2+
0)%62-2+/)='311%2(7'6)%8-2+%(3*-0)
+)88-2+(%8%-2838,)7,%4)2))()(*36%2%0=7-7
%2(',)'/-2+*36)6636736)%(:%2')(0)'896)7
;-00*3'973297-2+ 8%8%*366)+6)77-32%2(
796:-:%0%2%0=7-7%780=8,)6);-00&)0)'896)7
32():)034-2+430-7,)(1%297'6-486)%(=8%&0)7
%2(*-+96)7
!#" 
2013-14 GCSRT Program Scholars
2
3
“GCSRT is a great opportunity for focusing
o
n the concepts of epidemiology, clinical
trials, and biostatistics.”
Santi Trimarchi, MD, PhD
U
niversity of Milan, San Donato Milanese, Italy
"!"  
“The online courses provide flexibility in my
schedule, and the workshops are a valuable tool
for networking and for team building.”
Krishna Soujanya Gunturu, MD
Tufts Medical Center, Boston, Mass., USA
GLOBAL CLINICAL SCHOLARS RESEARCH TRAINING PROGRAM
HMS.HARVARD.EDU/GCSRT
B101 - Survey Design
!,-7'3967)'3:)678,)'6%*8-2+3*796:)=
59)78-3278,)()7-+23*796:)=7%2((-**)6)28
7%140-2+463')(96)78,%8%6)97)(-246%'8-')
32+78%2(-2+&%7-'46-2'-40)73*796:)=()7-+2
%6)'3:)6)( 8%8-78-'%0%74)'873*%2%0=>-2+
'3140)<796:)=(%8%;-00&)*)%896)( -2'09(-2+
8,))**)'873*(-**)6)28()7-+2*)%896)732&-%7
%2(:%6-%2')-**)6)281)8,3(73*:%6-%2')
)78-1%8-32*36786%8-*-)(%2('0978)6)(7%140)7
;-00&)'314%6)(!,),%2(0-2+3*796:)=
;)-+,87;-00&)(-7'977)(!,)'%4%&-0-8-)73*
8%8%*3679',%2%0=7)7;-00&))14,%7->)(
B102 - Drug Development, Drug Regulation,
and Drug Safety
69+():)0341)28(69+6)+90%8-32%2((69+
7%*)8=%6)'3140)<%2(,-+,0=-28)66)0%8)(
%'8-:-8-)78,%8-2:30:)&6-2+-2+%4,%61%')98-'%0
(-%+2378-'36():-')(-7'3:)6=83%4463:%0
%2(1%6/)8 )1-2%6834-'7-2'09()How are
Drugs Discovered and DevelopedCase
Study of the Pre-clinical Stages of Drug
DevelopmentMoving a Compound Through
the Drug Development ProcessGood
Manufacturing Practices---a Global Perspective
%2(Overview of Diagnostic Device Develop-
ment:)6:-);73*(69+6)+90%8-32*3'97-2+
328,)%'8-:-8-)73*8,)" 33(%2(69+
(1-2-786%8-32%2(9634)%2)(-'-2)7
+)2'=%6)%073'3:)6)(%780=0)'896)732
(69+7%*)8=-2'09()8,)*3003;-2+834-'7
Methods in Drug Safety Monitoring %2(
Drug Safety in the Pre- and Post-approval
Phases!,)'3967)-70%6+)0=;)&-2%6&%7)(
%2('327-7873*(-7'977-327&=)<4)687*631
%'%()1-%-2(9786= %2(+3:)621)28;-8,
=)%673*,%2(732)<4)6-)2');-8,0%6+)%2(
71%004,%61%')98-'%0&-38)',2303+=%2(
6)0%8)(36+%2->%8-327
C101 - Principles and Practice of
Clinical Trials
!,-7'3967)*3'97)732,3;83'32(9'8
'0-2-'%086-%07)**)'8-:)0=!,)'3967)'328)28
-2'09()70)'896)732789(=()7-+2%2(
-140)1)28%8-32-2'09(-2+(-**)6)28()7-+27
)2(43-287789(=46383'30789(=43490%8-32
6)'69-81)28&%7)0-2)%77)771)286%2(31
->%8-32786%8-*-'%8-32%2(&0-2(-2+8,)6/)=
-779)78,%8%6)'3:)6)(-2'09()(%8%%2%0=7-7
%2(7%140)7->)%2(43;)686)%81)28
6)+-1)27%2(*3003;94463')(96)7%2(
132-836-2+%2(-28)6-1%2%0=7-740%27
%780=38,)6%6)%7'3:)6)(-2'09()(%8%
1%2%+)1)28%2()8,-'%0-779)7-2'09(-2+
4638)'8-323*,91%279&.)'87
C102 - Introduction to Advanced
Quantitative Methods
!,-7'3967);-00463:-()789()287;-8,8,)
%440-'%8-323*%(:%2')(59%28-8%8-:)1)8,3(7
%78,)=4)68%-283!86%270%8-32%06)7)%6',
!34-'7-2'09()%23:)6:-);3*'314%6%8-:)
%2('378)**)'8-:)2)776)7)%6',1)8%
%2%0=7-759%7-)<4)6-1)28%0()7-+27
-2'09(-2+-278691)28%0:%6-%&0)7%2(1%6+-2%0
7869'896%013()0-2+4634)27-8=7'36)7%2(
8-1)7)6-)7%2%0=7-7
!#" 
!#" 
?&=8,)6)7-()28%2()003;73*%6:%6(300)+)
GLOBAL CLINICAL SCHOLARS RESEARCH TRAINING PROGRAM
PROGRAM CURRICULUM
JUNE 21, 2014 TO JUNE 6, 2015
!,)%6:%6()(-'%0 ',33003&%00-2-'%0 ',30%67)7)%6',!6%-2-2+
 !63+6%1'966-'9091-7()7-+2)(83)2%&0)7',30%6783():)034
/23;0)(+)%2(7,%64)27/-007-2'0-2-'%06)7)%6',
"!!#" 
!,)'966-'9091B7*392(%8-32%2()0)'8-:)'3967)7%003;7',30%67833&8%-2
%&63%(*92(3*/23;0)(+)-2'0-2-'%06)7)%6',%2(8,)23:)60%=74)'-%0->)(
-2*361%8-32-28,)-6'32')286%8-323*)-8,)6%(:%2')()4-()1-303+=
4- !36'0-2-'%086-%07!6-%07 !
38,'32')286%8-3276)59-6)7',30%67838%/)8,))0)'8-:)'3967)7%2(
8,)-6',3-')3*)0)'8-:)'3967)7)4)2(-2+328,)'32')286%8-327',30%67
;-008%/))-8,)6Principles and Practice of Clinical Trials 36Introduction to
Advanced Quantitative Methods -28,))0)'8-:)'3967)7
 !!
!6%-2-2+-240%22-2+%2(;6-8-2+%'0-2-'%06)7)%6',463437%0;-00&)%''31
40-7,)(8,639+,8,)%47832)63.)'8%92',)((96-2+$36/7,34
7',30%67;-00():)034%6)7)%6',59)78-32%2(&)+-2;6-8-2+8,)-6463437%07
))(&%'/328,)463437%0;-00&)463:-()(&=*%'908=
(6%*83*8,)463437%0-7(9)%6',8,)(%=%*8)6746-2+&6)%/
)2(7!,-7(6%*8;-00&)6):-);)(&=4))67%2(*%'908=&)*36)7',30%67
():)0348,)-6*-2%0:)67-327%2(79&1-88,)132%=!,)834
3*7',30%67;-00&)-2:-8)(8346)7)288,)-6789(-)7(96-2+$36/7,34
 !"""!
GLOBAL CLINICAL SCHOLARS RESEARCH TRAINING PROGRAM
HMS.HARVARD.EDU/GCSRT